Effect of dizocilpine maleate on monoamines and their metabolites in rat brain.
Systemic (ip) injection of dizocilpine maleate (DM, 0.1 and 0.5 mg.kg-1) increased the levels of 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid but did not bring about any noticeable change in the dopamine (DA) level in the striatum and limbic area. DM also increased the levels of norepinephrine in the limbic area and 5-hydroxyindoleacetic acid in the hippocampus. Amphetamine increased DA level and reduced DOPAC level in the striatum and limbic area. The behavioral manifestations revealed that DM predominantly evoked circling behavior and ataxia. The results indicate that the mechanism of the behavioral effect of DM may be different from that of amphetamine.
Ping
H X
HX
Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Xie
L
L
Gong
X J
XJ
Liu
G Q
GQ
Wu
H Q
HQ
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D015306:Biogenic Monoamines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D008032:Limbic System / Q000378:metabolism; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains
D015306:Biogenic Monoamines; D015102:3,4-Dihydroxyphenylacetic Acid; D016291:Dizocilpine Maleate; D000661:Amphetamine; D004298:Dopamine